• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射Δ9-四氢大麻酚:对通气控制和心血管动力学的影响。

Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.

作者信息

Malit L A, Johnstone R E, Bourke D I, Kulp R A, Klein V, Smith T C

出版信息

Anesthesiology. 1975 Jun;42(6):666-73.

PMID:1130738
Abstract

Delta9-Tetrahydrocannabinol (THC), the active component of marijuana, was studies to determine whether it might be useful for preanesthetic medication. Ten healthy subjects received THC intravenously in logarithmically spaced incremental doses. Four subjects received a total cumulatine dose of 135 mug/kg and four others, 201 mug/kg, Two of the ten subjects discontinued the study because of anxiety reactions. Ventilatory minute volume at a controlled elevated CO2 tension, 48 plus or minus 2 (SD) torr, changed minimally with TCH, -0.49 1/min/50 per cent increase in dose. TCH shifted the ventilatory response to CO22.7 torr destrad at 20 1/min without a change in slope. Dose-related tachycardia was the most marked cardiovascular effect. Heart rates increased to more than 100/min in five of six subjects. Cardiac index increased from 4.04 plus or minus 0.62 1/min/m-2 before TCH to 6.92 plus or minus 2.34 1/min/m-2 after 134 mug/kg. Mean arterial pressure increased slightly, and total peripheral resistance fell. The cardiovascular changes suggest beta-adrenergic stimulation. Intense mental effects and anxiety prohibited higher THC doses.

摘要

大麻的活性成分Δ9-四氢大麻酚(THC)被用于研究其是否可用于麻醉前用药。10名健康受试者静脉注射递增剂量的THC,剂量按对数间距递增。4名受试者接受的总累积剂量为135μg/kg,另外4名受试者为201μg/kg。10名受试者中有2名因焦虑反应而中断研究。在控制的二氧化碳分压升高至48±2(标准差)托时,每分钟通气量随THC的变化极小,剂量每增加50%,每分钟通气量减少0.49升/分钟。THC使对二氧化碳的通气反应在每分钟20升时右移2.7托,斜率无变化。与剂量相关的心动过速是最明显的心血管效应。6名受试者中有5名心率增加到超过100次/分钟。心脏指数从THC给药前的4.04±0.62升/分钟/平方米增加到134μg/kg给药后的6.92±2.34升/分钟/平方米。平均动脉压略有升高,总外周阻力下降。心血管变化提示β-肾上腺素能刺激。强烈的精神效应和焦虑使得无法使用更高剂量的THC。

相似文献

1
Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.静脉注射Δ9-四氢大麻酚:对通气控制和心血管动力学的影响。
Anesthesiology. 1975 Jun;42(6):666-73.
2
Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics.
Anesthesiology. 1975 Jun;42(6):674-84. doi: 10.1097/00000542-197506000-00009.
3
Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.涉嫌在大麻影响下驾驶的司机的心率频率和不规律性。
Eur J Intern Med. 2008 Dec;19(8):608-12. doi: 10.1016/j.ejim.2007.06.031. Epub 2008 Apr 18.
4
Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.大鼠体内δ8-和δ9-四氢大麻酚的血管收缩作用
J Pharmacol Exp Ther. 1976 Mar;196(3):649-56.
5
Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.Δ9-四氢大麻酚及其代谢物11-羟基-Δ9-四氢大麻酚的比较药理学
J Clin Invest. 1973 Oct;52(10):2411-7. doi: 10.1172/JCI107431.
6
The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeys.对恒河猴重复给予 Δ⁹-四氢大麻酚的心血管和自主神经效应。
J Pharmacol Exp Ther. 1981 Feb;216(2):247-53.
7
Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.新型硝酸酯类药物ITF 296在健康志愿者静脉给药后的安全性和药理活性。
J Cardiovasc Pharmacol. 1995;26 Suppl 4:S72-9.
8
Cardiovascular and respiratory effects of cannabis extracts and 1-tetra-hydrocannabinol ( 1-THC).大麻提取物和1-四氢大麻酚(1-THC)对心血管和呼吸系统的影响。
Br J Pharmacol. 1973 Mar;47(3):627P.
9
Certain observations on interrelationships between respiratory and cardiovascular effects of (-)- 9 -trans-tetrahydrocannabinol.关于(-)-9-反式-四氢大麻酚呼吸与心血管效应之间相互关系的某些观察
Res Commun Chem Pathol Pharmacol. 1972 May;3(3):483-92.
10
Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.Δ⁹-四氢大麻酚、欣快感与人的眼压
Ann Ophthalmol. 1975 Jul;7(7):921-3.

引用本文的文献

1
Δ-Tetrahydrocannabinol Effects on Respiration and Heart Rate Across Route of Administration in Female and Male Mice.Δ-四氢大麻酚对女性和男性小鼠给药途径的呼吸和心率的影响。
Cardiovasc Toxicol. 2023 Dec;23(11-12):349-363. doi: 10.1007/s12012-023-09810-9. Epub 2023 Sep 20.
2
Cannabis and Athletic Performance.大麻与运动表现。
Sports Med. 2021 Sep;51(Suppl 1):75-87. doi: 10.1007/s40279-021-01505-x. Epub 2021 Sep 13.
3
The Effects of Cannabis: Implications for the Surgical Patient.大麻的影响:对外科手术患者的启示
Plast Reconstr Surg Glob Open. 2021 Mar 15;9(3):e3448. doi: 10.1097/GOX.0000000000003448. eCollection 2021 Mar.
4
Cannabidiol activation of vagal afferent neurons requires TRPA1.大麻二酚激活迷走传入神经元需要 TRPA1。
J Neurophysiol. 2020 Nov 1;124(5):1388-1398. doi: 10.1152/jn.00128.2020. Epub 2020 Sep 23.
5
Cannabis Extract CT-921 Has a High Efficacy-Adverse Effect Profile in a Neuropathic Pain Model.大麻提取物CT-921在神经性疼痛模型中具有高效能-不良反应特征。
Drug Des Devel Ther. 2020 Aug 17;14:3351-3361. doi: 10.2147/DDDT.S247584. eCollection 2020.
6
Priming primary care providers to engage in evidence-based discussions about cannabis with patients.为初级保健提供者提供培训,使其能够与患者就大麻进行基于证据的讨论。
Addict Sci Clin Pract. 2019 Dec 2;14(1):42. doi: 10.1186/s13722-019-0171-3.
7
Surgical considerations of marijuana use in elective procedures.择期手术中使用大麻的外科手术考量
Heliyon. 2018 Sep 15;4(9):e00779. doi: 10.1016/j.heliyon.2018.e00779. eCollection 2018 Sep.
8
Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys.阿片类药物单独使用和与大麻素联合使用对恒河猴的通气抑制作用。
Eur J Pharmacol. 2018 Aug 15;833:94-99. doi: 10.1016/j.ejphar.2018.05.041. Epub 2018 May 26.
9
Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat.孤束核中的大麻素受体激活在大鼠中产生类似压力感受性反射的反应。
Int J Biomed Sci. 2008 Sep;4(3):229-37.
10
The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.有病例历史的静脉内给予 Δ⁹-四氢大麻酚的人体研究的安全性。
Psychopharmacology (Berl). 2012 Feb;219(3):885-96. doi: 10.1007/s00213-011-2417-y. Epub 2011 Aug 16.